position,0.590113
earnings results,-0.283524
52-week low,-0.760462
Uniqure NV Daily,0.417999
Asset Management LLC,0.288272
lipoprotein lipase deficiency,-0.68643
stock,0.36953
hold rating,0.347544
52-week high,-0.760462
InvestorPlace Broker Center,0.555736
orphan metabolic disease,-0.817079
Friday,0.210135
Perceptive Advisors LLC,0.590113
Uniqure NV,-0.376871
Zacks Investment Research,0.40995
personal trading style,0.598412
UNIQURE B.V.,-0.470139
buy rating,0.347544
research note,0.212269
research offerings,0.40995
Perceptive Advisors,0.604353
consensus estimate,0.206507
shares,0.350077
acquired diseases,-0.470139
gene therapy,-0.470139
concise daily summary,0.51698
average target price,-0.323207
MarketBeat reports,-0.286455
stock broker,0.245696
company,-0.466687
consensus rating,0.439023
Asset Management,0.288272
rating,0.295153
Eventide Asset Management,0.288272
quarter,0.498993
